Abstract Most pathogens in intestine are opportunist, called ''opportunistic pathogens'' that usually do not cause disease in a healthy host. Only when the host's resistance is lowered or the intestinal microecological balance is destroyed, the opportunistic pathogens are capable of causing disease. Here, two opportunistic pathogens, Salmonella enteritidis and Vibrio parahaemolyticus were chosen to test the possible antagonistic effect of the probiotic agent Clostridium butyricum on these pathogens infections in vitro using fish intestinal epithelial cells (FIECs). The C. butyricum and its spent culture supernatants exhibited significant inhibitory activity on S. enteritidis and V. parahaemolyticus growth and adherence to FIECs. The C. butyricum also showed significant inhibitory effects on S. enteritidis and V. parahaemolyticus induced apoptosis, which may due to its growth and adhesion inhibitory effects. These results indicated that the probiotic bacterium C. butyricum has preventive and therapeutic effects on S. enteritidis and V. parahaemolyticus infections in fish.
Introduction
The gastrointestinal tract of fish is colonized by a vast and dynamic consortium of microorganisms, which is a complex system [1, 2] . Disruption of intestinal microflora induced by the colonization of pathogenic bacteria causes intestinal infection, which can be controlled directly or indirectly by microbe-related factors [3] . Inhibition of the spread of pathogens helps maintain microbial homeostasis and prevent diseases. Probiotics are likely to play this role and therefore could be used to prevent disturbances of microflora in fish intestine and to treat pathogen-induced intestinal disease [4, 5] .
In aquaculture, probiotics that is known to exert a wide range of beneficial effects to their hosts, open a new era in health management strategy. Probiotics have proven useful in preventing and treating diarrhea, boosting immune competence and providing nutritional benefits. Adhesion to the host intestine surfaces represents the first step in most infections caused by pathogens [6] . Therefore, though interfering with the adhesion and establishment of pathogenic bacteria, probiotics contribute to the disease prevention and/or treatment [7, 8] , which is considered as one of the major beneficial effects of probiotics.
The Clostridium butyricum MIYAIRI II588 has been used to prevent disturbances of microflora and treat diarrhea [9] . Understanding the capacity of this probiotic to compete with pathogens will support our attempts to further characterize the beneficial properties of it. A study was designed for this purpose, employing the fish intestine epithelial cells (FIECs) isolated from catfish and two opportunistic pathogenic bacteria, enteropathogenic Salmonella enteritidis and Vibrio parahaemolyticus.
Materials and Methods

Bacterial Strains
The C. butyricum MIYAIRI II588 strain used in this study was obtained from Miyarisan Pharmaceutical Co. Ltd, Tokyo, Japan. It was cultured in MRS broth at 37°C in an anoxic environment. Enteropathogenic S. enteritidis and V. parahaemolyticus were obtained from the China Center of Industrial Culture Collection and cultured in LB broth.
Isolation and Culture of Fish Intestinal Epithelial Cells
Apparently healthy Crucian carp were used for this study. The FIECs were prepared and cultured according to a previous method [10] .
Antimicrobial Activity
The inhibitory effects of C. butyricum on S. enteritidis and V. parahaemolyticus growth were determined using spoton-the-lawn antagonism method according to a previously published method [11] . Plates of MRS agar were spotted with C. butyricum or MRS broth and incubated at 28°C for 18 h. A layer of 5 ml of LB broth with 0.8 % soft agar containing 40 ll of overnight cultures of the S. enteritidis or V. parahaemolyticus was poured over the plate, and cultured at 28°C for 48 h in static conditions. After incubation, growth inhibition was detected by measurement of the clear zone around the producer strain.
The effects of spent culture supernatants (SCS) from C. butyricum on the growth of S. enteritidis or V. parahaemolyticus were assessed using the agar plate diffusion test, according to published method with some modifications [12] . The SCS from C. butyricum were obtained by centrifugation of bacterial culture at 10,000 9 g (4°C) for 30 min. The collected SCS were then sterilized through a sterile filter (0.22 lm) and concentrated twofold by freezedrying. Because the pH of the MRS broth after a 24 h culture of C. butyricum was pH 5.0, we also used an SCS control with pH adjusted to 7.0. Sterilized LB agar was dispensed into petri dishes. Two wells per dish were made using a 14-mm-diameter gel punch. A total volume of 450 ll (3 9 150 ll) from SCS or MRS broth control was added to the respective well. To speed up the diffusion, the dishes were incubated (50°C) after each addition of 150 ll. From the stationary growth phase of S. enteritidis or V. parahaemolyticus, 500 ll of 1 9 10 5 CFU/ml was added to 5 ml LB broth (45°C) containing 0.8 % agar. The agar was rapidly dispersed and poured into the dishes, which were then incubated overnight before assessment of the diameters of the inhibition zones.
Adhesion Inhibition Assay
An adhesion inhibition assay was performed according to a previously described method [10] . Three different procedures were used in order to differentiate exclusion, competition or displacement of the S. enteritidis or V. parahaemolyticus by C. butyricum. The two bacteria were collected and re-suspended in 1640 media at a density of 10 8 CFU/ml. For exclusion tests, intestinal cell monolayers were cultured and washed three times with PBS solution and incubated with C. butyricum for 30 min. Then, nonadherent bacteria were removed, and S. enteritidis or V. parahaemolyticus was added and incubated for a further 30 min. For the competition test, C. butyricum, the pathogens and intestinal cells were mixed and incubated for 1 h. For the displacement test, the pathogens and intestinal cells were incubated together for 30 min. After removal of non-adherent pathogens, C. butyricum was added, and incubated for a further 30 min.
We also assessed the inhibitory effects of SCS from C. butyricum on adhesion of pathogens to intestinal cells. The S. enteritidis or V. parahaemolyticus was pre-treated by incubating in 25 ml SCS for 1 h and collected by centrifugation. The pathogen was then washed three times with PBS solution and re-suspended in 1640 media before infecting the cells [11] . Finally, the pathogen was added to intestinal cells and incubated for 1 h.
After incubation, all epithelial cells were washed three times with PBS solution, fixed in PBS containing 4 % (w/v) paraformaldehyde and observed microscopically following Gram staining. For each well, 50 cells with S. enteritidis or V. parahaemolyticus were inspected to assess the number of them attached to cells. Each assay was conducted at least in triplicate [12] .
Stimulation of Cells
The IECs were allowed to attach and grow in 6-well tissue culture plates (Costar) for 48 h. Before stimulation assays, the bacteria were collected and re-suspended in antibioticfree 1640 media at a density of 1 9 10 8 CFU/ml. Then, the IECs were then co-incubated with 1640 media, C. butyricum, the pathogen, a mixture of these two bacteria in 5 % CO 2 at 37°C for 2 h. After incubation, the cells were collected for assessment of apoptotic and necrotic cells [13] .
Assessment of Apoptotic and Necrotic Cells
Apoptosis and necrosis of IECs were assessed using an Annexin V-FITC Apoptosis Detection Kit (BD company, USA). The cells were stained with annexin V-fluorescein isothiocyanate (Annexin V-FITC) and propidium iodide (PI) for analyses by flow cytometry. The FITC and PI fluorescence were measured through 530 and 585 nm emission, respectively. Positioning of quadrants on Annexin V/PI dot plots was performed. [14] .
Tunel Assay
The Tunel assay was performed according to the manufacturer's investigational package (Takara Biotechnology, Dalian, China). The cells were fixed with 4 % paraformaldehyde/PBS (pH 7.4) and washed with PBS. Endogenous peroxidase was inactivated with methanol containing 0.3 % H 2 O 2 , and then the cells were permeabilized by permeabilisation buffer and incubated with labeling reaction mixture (consisting of TdT Enzyme and labeling safe buffer) using In situ Apoptosis Detection kit. The FITClabeled Tunel-positive cells were imaged by fluorescent microscopy.
Statistical Analysis
All statistical analyses were performed using Statistical Analysis System software (SAS V8). All results are shown as the average of at least three replicates. Data are presented as means ± the standard error (SE). Duncan's multiple range tests were used to evaluate the statistical significance of the results. Differences with p values of \0.05 were considered significant.
Results
Growth Inhibition of S. enteritidis and V. parahaemolyticus by C. butyricum and its SCS
In order to determine whether C. butyricum is able to inhibit the growth of pathogens, the anti-bacterial activity of the C. butyricum was assayed using the spot-on-the-lawn antagonism method. Clostridium butyricum has previously shown effectiveness against Aeromonas hydrophila and Vibrio anguillarum [10] , and here it was found that C. butyricum had clear growth inhibition to S. enteritidis and V. parahaemolyticus (Table 1) . We also investigated whether metabolite produced by C. butyricum inhibit the S. enteritidis and V. parahaemolyticus growth. The results of the agar plate diffusion tests, which are presented in Table 1 , clearly show that the SCS significantly inhibited the growth of S. enteritidis and V. parahaemolyticus (Table 1 ). It was found that the pH of medium after a 20 h culture of C. butyricum was pH 5.0. When the SCS was neutralized to pH 7.0, the anti-bacterial activity of SCS against S. enteritidis and V. parahaemolyticus decreased. Thus, these organic acids produced by C. butyricum during the process of fermentation, which lower the pH of medium, play an important role in inhibiting the growth of pathogens.
Inhibition of S. enteritidis and V. parahaemolyticus
Adherence to IECs by C. butyricum and its SCS Inhibition of S. enteritidis and V. parahaemolyticus adhesion to IECs was tested in displacement, exclusion and competition assays. As shown in Fig. 1 , the number of S. enteritidis and V. parahaemolyticus adhesion to IECs were all reduced significantly by C. butyricum when compared with untreated group in exclusion, competition and displacement experiments. In addition, no significant differential influence of C. butyricum on the adhesion of S. enteritidis and V. parahaemolyticus was noted (Fig. 1) . These findings suggest that the C. butyricum possesses the ability to inhibit S. enteritidis and V. parahaemolyticus adherence to IECs.
Clostridium butyricum Prevents S. enteritidis or V. parahaemolyticus Induced Cell Apoptosis
Since we found that C. butyricum inhibited S. enteritidis and V. parahaemolyticus growth and adhesion, we then investigated the effects of C. butyricum on cell apoptosis induced by these two pathogens. Firstly, the induction of apoptosis was determined by flow cytometry with Annexin V-FITC/PI double staining, which reveals the rates of early, late and total apoptosis. The S. enteritidis and V. parahaemolyticus treatment resulted in a large increase in both early and late apoptosis rates. However, C. butyricum significantly reduced the rates of both early and late apoptosis (Fig. 2a) . Following detection of cell apoptosis by flow cytometry with Annexin V-FITC/PI double staining, the cell apoptosis was also observed by Tunel staining. As shown in Fig. 2b , the morphologic assessments of apoptosis by Tunel staining was well matched with the flow cytometry data (Fig. 2b) , which further confirmed that C. butyricum could inhibit S. enteritidis and V. parahaemolyticus induced cell apoptosis. The cells of the control group appeared normal, whereas the cells treated with S. enteritidis or V. parahaemolyticus exhibited significant apoptosis (Fig. 2a) . However, when these cells were coincubated with C. butyricum, the number of Tunel-positive cells was significantly decreased (Fig. 2b) .
Discussion
Today probiotics, well-known for their disease preventing and health promoting properties, are quite commonplace in health-promoting functional foods for humans, as well as therapeutic prophylactic and growth supplements in animal production [15] . Typically, the C. butyricum that is a natural resident of human and animal gut, has been widely used to prevent disturbances of microflora in human intestine and to treat diarrhea, enhance humoral immune response, promote digestion, improve meat quality and increase growth performance in animals [16, 17] . In the present study, this strain was chosen in order to evaluate its potential capacity for preventing pathogen-induced diseases in fish, which may help to reach a better understanding of C. butyricum.
When looking at probiotics intended for an aquatic usage, their antimicrobial activity appears to be more important. Because aquatic animals have a much closer relationship with their external environment in which potential pathogens are able to maintain themselves and proliferate independently of host animals, and thereby are more susceptible to pathogens [18] . Our data indicate that the C. butyricum is effective in inhibiting growth of S. enteritidis and V. parahaemolyticus, which is in agreement with previous reports [19] . Additionally, the SCS from C. butyricum remarkably inhibited the proliferation of S. enteritidis and V. parahaemolyticus. When the pH was adjusted to 7.0, a remarkable reduction in this inhibition was observed, but it was still significant compared with control, which suggests that in addition to short chain fatty acids, no-acidic metabolites could also contribute to antibacterial activity of C. butyricum. It can be hypothesized that the organic acids produced by C. butyricum during the process of fermentation may serve to lower the pH in intestine, and together with non-acidic metabolites prevent the proliferation of harmful species of bacteria and facilitate that of helpful species, which may help to create an optimal intestinal environment. In this ecological niche, most beneficial bacteria are more at home and are more successful in the antagonism.
The S. enteritidis and V. parahaemolyticus tended to adhere in large numbers to fish intestinal cells, however, the adhesion capacity of them was significantly reduced after exposure of intestinal cells to C. butyricum. This suggests that the S. enteritidis and V. parahaemolyticus Fig. 1 The effects of C. butyricum on adhesion of S. enteritidis and V. parahaemolyticus to IECs were examined in co-incubated (competition), pre-incubated (displacement) and post-incubated (exclusion) assays. Different letters indicate significant differences (p \ 0.01) have the ability to bind to fish intestinal epithelium, which may help explain their virulence, and the intestine is a key possible route of infection for S. enteritidis and V. parahaemolyticus as well as an important target for probiotic treatments. Furthermore, the probiotic interference with pathogens adherence is highly specific and usually depends on probiotic, pathogen and source of intestinal cells [6] . Therefore, our data could open up a new therapeutic perspective in the prevention and treatment of intestinal diseases caused by S. enteritidis and V. parahaemolyticus in aquaculture.
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Through inhibiting S. enteritidis and V. parahaemolyticus growth and adhesion to their receptors, a decrease in the levels of cell apoptosis induced by these two pathogens would be presented, and in this way would result in a reduction in pathogenicity and virulence. Indeed, the C. butyricum showed significant inhibitory effects on S. enteritidis and V. parahaemolyticus induced apoptosis (Fig. 2) . Since the induction of apoptosis by pathogens is always involved in the pathogenesis of many diseases [20] , this property could further suggests that the C. butyricum possesses the capacity for treating S. enteritidis and V. parahaemolyticus infected aquatic animals, and is worth further investigation in vivo. Our data also showed a hierarchical effect with the pathogens provoking a strong apoptotic response, however, the C. butyricum initiating a mild effect. This may result from the adaptive coevolution of animals and symbiotic bacteria [21] .
Take together, this work strongly suggest that the probiotic strain, C. butyricum could provide protection against S. enteritidis and V. parahaemolyticus infections in fish. Furthermore, since the C. butyricum exhibited significant inhibitory activity on S. enteritidis and V. parahaemolyticus growth and adhesion, it is possible that the C. butyricum could inhibit the spread of opportunistic pathogens and optimize the gut flora, and thereby promote health and increase growth performance in fish food farming. This provides further evidence on the probiotic potential of the C. butyricum. On the basis of these encouraging in vitro results, in vivo studies on application of C. butyricum in aquaculture should be carried out.
